Agent for treating chronic pelvic pain syndrome
AssigneeAstellas Pharma Inc.
InventorsMiki Kobayashi, Satoshi Kubo
Life of this patent
Estimating the term…
Abstract
This invention relates to an agent for preventing or treating chronic pelvic pain syndromes (chronic abacterial prostatitis, chronic pelvic pain syndrome in a narrow sense and interstitial cystitis), which comprises various phosphodiesterase 4 (PDE 4) inhibitors such as cilomilast and roflumilast as an active ingredient.
Claims11
A composition for preventing or treating chronic pelvic pain syndrome, which comprises a phosphodiesterase 4 (PDE 4) inhibitor, or a pharmaceutically acceptable salt thereof, as an active ingredient.
(canceled)
(canceled)
(canceled)
(canceled)
A method of preventing or treating chronic pelvic pain syndrome comprising administering an effective amount of a PDE 4 inhibitor, or pharmaceutically acceptable salt thereof, to a subject.
Dependencies are inferred from the claim text.